Exact Mass: 159.0899

Exact Mass Matches: 159.0899

Found 156 metabolites which its exact mass value is equals to given mass value 159.0899, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Betonicine

(2S-trans)-2-Carboxylato-4-hydroxy-1,1-dimethylpyrrolidinium

C7H13NO3 (159.0895)


Betonicine (4-hydroxy-L-prolinebetaine) and its cis isomer, turicine, are naturally occurring substituted pyrrolidines. It is not naturally produced by humans and can only be obtained through consumption of certain plant products. Betonicine was used as an analgesic 1000 years ago and is still available commercially from herbalists today. Betonicine has been isolated from Achillea millefolium L. (common yarrow) and probably from A. atrata L. (black yarrow); it is an alkaloid. Betonicine has been identified as a metabolically inert cell protectant that protects plants against extremes in osmolarity and growth temperatures. Betonicine is found in the fruit juices of yellow orange, blood orange, lemon, mandarin and bitter orange (PMID: 21838291) KEIO_ID B090

   

5-Acetamidovalerate

5-acetamidopentanoic acid

C7H13NO3 (159.0895)


5-Acetamidovalerate is involved in the lysine degradation III pathway. It can be generated from the enzymatic reduction of 5-aminopentanoate or enzymatic oxidation of 2-keto-6-acetamidocaproate. Experiment using DL-{4,5-3H}lysine showed 5-acetamidovalerate as the major product. If radiolabeled N6-acetyl-L-lysine was used with added α-ketoglutarate, and pyridoxal phosphate, radiolabeled 2-keto-6-acetamidocaproate was produced. α-Ketoglutarate was preferred over pyruvate, and there was little or no dependence on pyridoxal phosphate. If thiamine pyrophosphate and NAD were added to a similar reaction, virtually all of the label was in 5-acetamidovalerate. If labeled 5-acetamidovalerate was used, labeled 5-aminovalerate (5-aminopentanoate) was identified. In addition, whole cell cultures of R. leguminicola incubated with labeled 5-acetamidovalerate accumulated radiolabeled glutarate. Whole cell cultures incubated with radiolabeled glutarate produced a mixture of tricarboxylic acid cycle acids and other carboxylic acids. 5-Acetamidovalerate is involved in the lysine degradation III pathway. It can be generated from the enzymatic reduction of 5-aminopentanoate or enzymatic oxidation of 2-keto-6-acetamidocaproate.

   

3-Hydroxystachydrine

3-Hydroxystachydrine

C7H13NO3 (159.0895)


   

Calystegin A3

8-azabicyclo[3.2.1]octane-1,2,3-triol

C7H13NO3 (159.0895)


Alkaloid from Solanum tuberosum (potato). Calystegin A3 is found in many foods, some of which are eggplant, alcoholic beverages, potato, and sweet potato. Calystegin A3 is found in alcoholic beverages. Calystegin A3 is an alkaloid from Solanum tuberosum (potato).

   

Turicine

(2R,4R)-4-hydroxy-1,1-dimethylpyrrolidin-1-ium-2-carboxylate

C7H13NO3 (159.0895)


   

Isovalerylglycine

2-(3-Methylbutanoylamino)ethanoic acid

C7H13NO3 (159.0895)


Isovalerylglycine (IVG) is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine < -- > CoA + N-acylglycine. Isovalerylglycine is a byproduct of the catabolism of the aminoacid leucine. Accumulation of isovalerylglycine occurs in Isovaleric Acidemia (IVA). IVA (OMIM/ McKusick 243500) is an autosomal recessive disorder caused by mutations in the isovaleryl-CoA dehydrogenase (EC 1.3.99.10) gene. The deficiency of this enzyme in the metabolism of leucine leads to the accumulation of a series of isovaleryl-CoA metabolites, such as isovalerylglycine. It is very important to caution for false positive results when screening for isovaleric acidemia by tandem mass spectrometry based on dried blood-spot levels of C5-acylcarnitines, including isovalerylcarnitine and its isomer, pivaloylcarnitine; pivaloylcarnitine is derived from pivalate-generating antibiotics, and has caused many false-positive results (PMID: 17850781). Isovalerylglycine is a biomarker for the consumption of cheese. Isovalerylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction: N-Isovaleroylglycine is an acyl glycine and could be used as a biomarker for the predispositon for weight gain and obesity.

   

N-Acetylvaline

(2S)-2-Acetamido-3-methylbutanoic acid

C7H13NO3 (159.0895)


N-Acetyl-L-valine or N-Acetylvaline, belongs to the class of organic compounds known as N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. N-Acetylvaline can also be classified as an alpha amino acid or a derivatized alpha amino acid. Technically, N-Acetylvaline is a biologically available N-terminal capped form of the proteinogenic alpha amino acid L-valine. N-acetyl amino acids can be produced either via direct synthesis of specific N-acetyltransferases or via the proteolytic degradation of N-acetylated proteins by specific hydrolases. N-terminal acetylation of proteins is a widespread and highly conserved process in eukaryotes that is involved in protection and stability of proteins (PMID: 16465618). About 85\\\% of all human proteins and 68\\\% of all yeast proteins are acetylated at their N-terminus (PMID: 21750686). Several proteins from prokaryotes and archaea are also modified by N-terminal acetylation. The majority of eukaryotic N-terminal-acetylation reactions occur through N-acetyltransferase enzymes or NAT’s (PMID: 30054468). These enzymes consist of three main oligomeric complexes NatA, NatB, and NatC, which are composed of at least a unique catalytic subunit and one unique ribosomal anchor. The substrate specificities of different NAT enzymes are mainly determined by the identities of the first two N-terminal residues of the target protein. The human NatA complex co-translationally acetylates N-termini that bear a small amino acid (A, S, T, C, and occasionally V and G) (PMID: 30054468). NatA also exists in a monomeric state and can post-translationally acetylate acidic N-termini residues (D-, E-). NatB and NatC acetylate N-terminal methionine with further specificity determined by the identity of the second amino acid. N-acetylated amino acids, such as N-acetylvaline can be released by an N-acylpeptide hydrolase from peptides generated by proteolytic degradation (PMID: 16465618). In addition to the NAT enzymes and protein-based acetylation, N-acetylation of free valine can also occur. Excessive amounts N-acetyl amino acids including N-acetylvaline(as well as N-acetylglycine, N-acetylserine, N-acetylmethionine, N-acetylglutamate, N-acetylalanine, N-acetylleucine and smaller amounts of N-acetylglutamine, N-acetylisoleucine, and N-acetylthreonine) can be detected in the urine with individuals with acylase I deficiency, a genetic disorder (PMID: 16465618). Aminoacylase I is a soluble homodimeric zinc binding enzyme that catalyzes the formation of free aliphatic amino acids from N-acetylated precursors. In humans, Aminoacylase I is encoded by the aminoacylase 1 gene (ACY1) on chromosome 3p21 that consists of 15 exons (OMIM 609924). Individuals with aminoacylase I deficiency will experience convulsions, hearing loss and difficulty feeding (PMID: 16465618). ACY1 can also catalyze the reverse reaction, the synthesis of acetylated amino acids. Many N-acetylamino acids, including N-acetylthreonine, are classified as uremic toxins if present in high abundance in the serum or plasma (PMID: 26317986; PMID: 20613759). Uremic toxins are a diverse group of endogenously produced molecules that, if not properly cleared or eliminated by the kidneys, can cause kidney damage, cardiovascular disease and neurological deficits (PMID: 18287557). N-acetylvaline is a derivative of valine, which is a branched chain essential amino acid. Valine is involved in carbohydrate metabolism. Valine deficiency is marked by neurological defects in the brain. Valine has also been established as a useful supplemental therapy to the ailing liver. [HMDB] Acetylvaline is an endogenous metabolite.

   

4-Hydroxystachydrine

(2R)-4-Hydroxy-1,1-dimethylpyrrolidin-1-ium-2-carboxylic acid

C7H13NO3 (159.0895)


4-hydroxystachydrine is a biomarker of citrus consumption found in urine.

   

3-Dehydrocarnitine

3-Carboxy-N,N,N-trimethyl-2-oxo-1-propanaminium

C7H13NO3 (159.0895)


3-Dehydrocarnitine is a member of the carnitine family that is an intermediate in carnitine degradation. It can be formed from either D-carnitine or L-carnitine and the enzyme responsible for this oxidation reaction is (S)-carnitine 3-dehydrogenase (EC 1.1.1.254) or Carnitine 3-dehydrogenase (EC 1.1.1.108) respectively. Carnitine is a quaternary ammonium compound biosynthesized from the amino acids lysine and methionine. In living cells, it is required for the transport of fatty acids from the cytosol into the mitochondria during the breakdown of lipids (or fats) for the generation of metabolic energy. [HMDB] 3-Dehydrocarnitine is a member of the carnitine family that is an intermediate in carnitine degradation. It can be formed from either D-carnitine or L-carnitine and the enzyme responsible for this oxidation reaction is (S)-carnitine 3-dehydrogenase (EC 1.1.1.254) or carnitine 3-dehydrogenase (EC 1.1.1.108), respectively. Carnitine is a quaternary ammonium compound biosynthesized from the amino acids lysine and methionine. In living cells, it is required for the transport of fatty acids from the cytosol into the mitochondria during the breakdown of lipids (or fats) for the generation of metabolic energy.

   

Calystegine A7

8-Azabicyclo[3.2.1]octane-1,2,4-triol

C7H13NO3 (159.0895)


Calystegine A7 is an alkaloid from the roots of Lycium chinense (Chinese boxthorn). Alkaloid from the roots of Lycium chinense (Chinese boxthorn)

   

Calystegine A6

8-Azabicyclo[3.2.1]octane-1,2,7-triol

C7H13NO3 (159.0895)


Calystegine A6 is found in coffee and coffee products. Calystegine A6 is an alkaloid from and Lycium chinense (Chinese boxthorn

   

Medicanine

1-(3-hydroxypropyl)azetidine-2-carboxylic acid

C7H13NO3 (159.0895)


Medicanine is found in pulses. Medicanine is a amino acid from seeds of Medicago sativa (alfalfa). Amino acid from seeds of Medicago sativa (alfalfa). Medicanine is found in pulses.

   

2-Methylbutyrylglycine

(2-Methyl-butyrylamino)-acetic acid

C7H13NO3 (159.0895)


2-Methylbutyrylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism, such as propionic acidemia. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine < -- > CoA + N-acylglycine. The isolated excretion of high levels of 2-methylbutyrylglycine (2-MBG) is the hallmark of short/branched-chain acyl-CoA dehydrogenase deficiency or SBCADD (PMID:15615815). The disorder is also called 2-methylbutyryl-CoA dehydrogenase deficiency (PMID: 17883863) and has been associated with autism and mental retardation. SBCADD is a recently described autosomal recessive disorder caused by a defect in the degradation pathway of L- isoleucine leading to increased urinary excretion of 2-methylbutyryl glycine. The enzymatic defect results from disruption of the SBCAD gene. Deficiency of SBCAD leads to accumulation of its substrate, 2-methylbutyryl-CoA within the mitochondrion. This substance is transesterified with glycine by the mitochondrial enzyme acyl-CoA glycine-N-acyltransferase (glycine-N-acylase) to form 2-methylbutyryl glycine. Affected patients can be divided into two categories. The first category consists of infants detected by newborn screening programmes. These infants are treated with diet and remain without clinical symptoms. In the second category affected patients are diagnosed because they presented clinically with seizures and psychomotor delay and have increased urinary excretion of 2-methylbutyryl glycine (PMID: 17883863). 2-methylbutyrylglycine has also been found in the urine of patients with propionyl-CoA carboxylase deficiency after consuming isoleucine. (PMID: 630060). 2-methylbutyrylglycine is also elevated in the urine of patients with glutaric aciduria II and ethylmalonic encephalopathy. 2-Methylbutyrylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:

   

Valerylglycine

2-[(1-Hydroxypentylidene)amino]acetate

C7H13NO3 (159.0895)


Valerylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:acyl-CoA + glycine < -- > CoA + N-acylglycineValerylglycine are identified based on their liquid chromatographic-atmospheric pressure chemical ionization mass spectra (LC-APCI-MS)(PMID:8548022). Valerylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:

   

Turicine

(2R,4R)-4-hydroxy-1,1-dimethylpyrrolidin-1-ium-2-carboxylate

C7H13NO3 (159.0895)


Turicine is a constituent of Canavalia ensiformis (jack bean)

   

Methyl 5-(hydroxymethyl)pyrrolidine-3-carboxylate

Methyl 5-(hydroxymethyl)pyrrolidine-3-carboxylic acid

C7H13NO3 (159.0895)


Methyl 5-(hydroxymethyl)pyrrolidine-3-carboxylate belongs to the class of organic compounds known as pyrrolidine carboxylic acids. These are compounds containing a pyrrolidine ring which bears a carboxylic acid. Pyrrolidine is a five-membered saturated aliphatic heterocycle with one nitrogen atom and four carbon atoms.

   

(2R,3S)-3-Hydroxy-1,1-dimethylpyrrolidin-1-ium-2-carboxylate

(2R,3S)-3-Hydroxy-1,1-dimethylpyrrolidin-1-ium-2-carboxylic acid

C7H13NO3 (159.0895)


   

2-Pivalamidoacetic acid

2-[(1-Hydroxy-2,2-dimethylpropylidene)amino]acetate

C7H13NO3 (159.0895)


   

2alpha,3beta,4alpha-Trihydroxynortropane

2alpha,3beta,4alpha-Trihydroxynortropane

C7H13NO3 (159.0895)


   

8-Azabicyclo[3.2.1]octane-1,3,4-triol

8-Azabicyclo[3.2.1]octane-1,3,4-triol

C7H13NO3 (159.0895)


   

2-Methylerythritol

2-Methylerythritol

C7H13NO3 (159.0895)


   

ac-dl-nva-oh

2-acetamidopentanoic acid

C7H13NO3 (159.0895)


   

4-methoxypiperidine-2-carboxylic acid

4-methoxypiperidine-2-carboxylic acid

C7H13NO3 (159.0895)


   

ethyl 2-hydroxyiminopentanoate

ethyl 2-hydroxyiminopentanoate

C7H13NO3 (159.0895)


   

2-amino-5-methyl-6-hydroxyhex-4-enoic acid

2-amino-5-methyl-6-hydroxyhex-4-enoic acid

C7H13NO3 (159.0895)


   
   

5-hydroxy-6-methylpipecolic acid

5-hydroxy-6-methylpipecolic acid

C7H13NO3 (159.0895)


   

8-azabicyclo[3.2.1]octane-2,3,4-triol

8-azabicyclo[3.2.1]octane-2,3,4-triol

C7H13NO3 (159.0895)


   

8-azabicyclo[3.2.1]octane-2,3,6-triol

8-azabicyclo[3.2.1]octane-2,3,6-triol

C7H13NO3 (159.0895)


   

Medicanine

1-(3-hydroxypropyl)azetidine-2-carboxylic acid

C7H13NO3 (159.0895)


   

2-amino-4-methyl-6-hydroxyhex-4-enoic acid

2-amino-4-methyl-6-hydroxyhex-4-enoic acid

C7H13NO3 (159.0895)


   

trans-n-methyl-4-methoxyproline

trans-n-methyl-4-methoxyproline

C7H13NO3 (159.0895)


   

2-Methylbutyrylglycine

2-Methylbutyrylglycine

C7H13NO3 (159.0895)


   

Isovalerylglycine

N-Isovalerylglycine

C7H13NO3 (159.0895)


N-Isovaleroylglycine is an acyl glycine and could be used as a biomarker for the predispositon for weight gain and obesity.

   

Valerylglycine

Valerylglycine

C7H13NO3 (159.0895)


   

N-Isovalerylglycine

N-Isovaleroylglycine

C7H13NO3 (159.0895)


An N-acylglycine in which the acyl group is specified as isovaleryl. N-Isovaleroylglycine is an acyl glycine and could be used as a biomarker for the predispositon for weight gain and obesity.

   

Betonicine; AIF; CE0; CorrDec

Betonicine; AIF; CE0; CorrDec

C7H13NO3 (159.0895)


   

Betonicine; AIF; CE10; CorrDec

Betonicine; AIF; CE10; CorrDec

C7H13NO3 (159.0895)


   

Betonicine; AIF; CE30; CorrDec

Betonicine; AIF; CE30; CorrDec

C7H13NO3 (159.0895)


   

Betonicine; AIF; CE0; MS2Dec

Betonicine; AIF; CE0; MS2Dec

C7H13NO3 (159.0895)


   

Betonicine; AIF; CE10; MS2Dec

Betonicine; AIF; CE10; MS2Dec

C7H13NO3 (159.0895)


   

Betonicine; AIF; CE30; MS2Dec

Betonicine; AIF; CE30; MS2Dec

C7H13NO3 (159.0895)


   

Isobutyrylglycine methyl ester

Isobutyrylglycine methyl ester

C7H13NO3 (159.0895)


   

Methyl N-butyrylglycine

Methyl N-butyrylglycine

C7H13NO3 (159.0895)


   

5-Acetamidovalerate

5-acetamidopentanoic acid

C7H13NO3 (159.0895)


   

Acetylvaline

2-Acetamido-3-methylbutanoic acid

C7H13NO3 (159.0895)


Acetylvaline is an endogenous metabolite.

   

4-Hydroxystachydrine

(2R)-4-hydroxy-1,1-dimethylpyrrolidin-1-ium-2-carboxylate

C7H13NO3 (159.0895)


   

Calystegine A6

8-Azabicyclo[3.2.1]octane-1,2,7-triol

C7H13NO3 (159.0895)


   

Calystegine A7

8-Azabicyclo[3.2.1]octane-1,2,4-triol

C7H13NO3 (159.0895)


   

3-Dehydrocarnitine

3-Dehydrocarnitine

C7H13NO3 (159.0895)


An ammonium betaine that is the conjugate base of 3-dehydrocarnitinium; major species at pH 7.3.

   

Cyclohexanol,1-(nitromethyl)-

Cyclohexanol,1-(nitromethyl)-

C7H13NO3 (159.0895)


   

ethyl 3-ethoxy-3-iminopropanoate

ethyl 3-ethoxy-3-iminopropanoate

C7H13NO3 (159.0895)


   

2-(r)-carboethoxy-4-(r)-hydroxypyrrolidine

2-(r)-carboethoxy-4-(r)-hydroxypyrrolidine

C7H13NO3 (159.0895)


   

Methyl 2-(morpholin-2-yl)acetate

Methyl 2-(morpholin-2-yl)acetate

C7H13NO3 (159.0895)


   

4-methoxy-piperidine-2-carboxylic acid

4-methoxy-piperidine-2-carboxylic acid

C7H13NO3 (159.0895)


   

Ethyl morpholinocarboxylate

Ethyl morpholinocarboxylate

C7H13NO3 (159.0895)


   

(4-HYDROXYPIPERIDIN-1-YL)ACETIC ACID

(4-HYDROXYPIPERIDIN-1-YL)ACETIC ACID

C7H13NO3 (159.0895)


   

(2S)-2-AMINO-3-(TETRAHYDROFURAN-3-YL)PROPANOIC ACID

(2S)-2-AMINO-3-(TETRAHYDROFURAN-3-YL)PROPANOIC ACID

C7H13NO3 (159.0895)


   

(2R)-2-AMINO-3-(TETRAHYDROFURAN-3-YL)PROPANOIC ACID

(2R)-2-AMINO-3-(TETRAHYDROFURAN-3-YL)PROPANOIC ACID

C7H13NO3 (159.0895)


   

1-(3-METHOXY-4,5-METHYLENEDIOXYPHENYL)-2-NITROETHANE

1-(3-METHOXY-4,5-METHYLENEDIOXYPHENYL)-2-NITROETHANE

C7H13NO3 (159.0895)


   

MORPHOLINE-3-ACETIC ACID METHYL ESTER

MORPHOLINE-3-ACETIC ACID METHYL ESTER

C7H13NO3 (159.0895)


   

2-morpholin-4-ylpropanoic acid

2-morpholin-4-ylpropanoic acid

C7H13NO3 (159.0895)


   

[(1,1-dimethylpropyl)amino](oxo)acetic acid

[(1,1-dimethylpropyl)amino](oxo)acetic acid

C7H13NO3 (159.0895)


   

tert-butyl 3-amino-3-oxopropanoate

tert-butyl 3-amino-3-oxopropanoate

C7H13NO3 (159.0895)


   

Methyl 4-hydroxy-4-piperidinecarboxylate

Methyl 4-hydroxy-4-piperidinecarboxylate

C7H13NO3 (159.0895)


   

2-AMINO-3-(TETRAHYDROFURAN-3-YL)PROPANOIC ACID

2-AMINO-3-(TETRAHYDROFURAN-3-YL)PROPANOIC ACID

C7H13NO3 (159.0895)


   

4-Piperidinecarboxylic acid, 4-hydroxy-1-methyl- (9CI)

4-Piperidinecarboxylic acid, 4-hydroxy-1-methyl- (9CI)

C7H13NO3 (159.0895)


   

Alanine, 2-methyl-N-(1-oxopropyl)- (9CI)

Alanine, 2-methyl-N-(1-oxopropyl)- (9CI)

C7H13NO3 (159.0895)


   

4-Piperidinecarboxylic acid,3-hydroxy-,methylester,cis-(9CI)

4-Piperidinecarboxylic acid,3-hydroxy-,methylester,cis-(9CI)

C7H13NO3 (159.0895)


   

Cis-Hexahydroisoindole Hydrochloride

Cis-Hexahydroisoindole Hydrochloride

C8H14ClN (159.0815)


   

2-METHOXYETHYL-4-AMINOCROTONATE

2-METHOXYETHYL-4-AMINOCROTONATE

C7H13NO3 (159.0895)


   

2-Methyl-2-propanyl (2-oxoethyl)carbamate

2-Methyl-2-propanyl (2-oxoethyl)carbamate

C7H13NO3 (159.0895)


   

prop-2-enyl N-(3-hydroxypropyl)carbamate

prop-2-enyl N-(3-hydroxypropyl)carbamate

C7H13NO3 (159.0895)


   

4-Morpholinepropionic acid

4-Morpholinepropionic acid

C7H13NO3 (159.0895)


   

(PHENYLDIMETHYLSILYL)METHYLMETHACRYLATE

(PHENYLDIMETHYLSILYL)METHYLMETHACRYLATE

C7H13NO3 (159.0895)


   

Methyl 4-aminotetrahydropyran-4-carboxylate hydrochloride

Methyl 4-aminotetrahydropyran-4-carboxylate hydrochloride

C7H13NO3 (159.0895)


   

4-methylpiperazine-1-carbothioamide

4-methylpiperazine-1-carbothioamide

C6H13N3S (159.083)


   

methyl 3-hydroxypiperidine-3-carboxylate

methyl 3-hydroxypiperidine-3-carboxylate

C7H13NO3 (159.0895)


   

Ethyl 2-(3-aminooxetan-3-yl)acetate

Ethyl 2-(3-aminooxetan-3-yl)acetate

C7H13NO3 (159.0895)


   
   

(+)-N-(O-CHLOROBENZYL)-ALPHA-METHYLPHENETHYLAMINEHYDROCHLORIDE

(+)-N-(O-CHLOROBENZYL)-ALPHA-METHYLPHENETHYLAMINEHYDROCHLORIDE

C7H13NO3 (159.0895)


   

(3R,4R)-4-Aminotetrahydropyran-3-carboxylic acid methyl ester

(3R,4R)-4-Aminotetrahydropyran-3-carboxylic acid methyl ester

C7H13NO3 (159.0895)


   

2-Pivalamidoacetic acid

[(2,2-Dimethylpropanoyl)amino]acetic acid

C7H13NO3 (159.0895)


   

α-Dimethoxymethyl-methoxypropionitrile

α-Dimethoxymethyl-methoxypropionitrile

C7H13NO3 (159.0895)


   

3-Morpholinecarboxylicacid,ethylester,(S)-(9CI)

3-Morpholinecarboxylicacid,ethylester,(S)-(9CI)

C7H13NO3 (159.0895)


   

2-BROMO-4-PHENYLACETOPHENONE

2-BROMO-4-PHENYLACETOPHENONE

C7H13NO3 (159.0895)


   

4-(aminomethyl)oxane-4-carboxylic acid

4-(aminomethyl)oxane-4-carboxylic acid

C7H13NO3 (159.0895)


   

ETHYL 2-MORPHOLINECARBOXYLATE

ETHYL 2-MORPHOLINECARBOXYLATE

C7H13NO3 (159.0895)


   

Methyl 5-hydroxy-3-piperidinecarboxylate

Methyl 5-hydroxy-3-piperidinecarboxylate

C7H13NO3 (159.0895)


   

Methyl 2-Homomorpholinecarboxylate

Methyl 2-Homomorpholinecarboxylate

C7H13NO3 (159.0895)


   

ETHYL 2-(N-METHYLACETAMIDO)ACETATE

ETHYL 2-(N-METHYLACETAMIDO)ACETATE

C7H13NO3 (159.0895)


   

N-Butyrylalanine

N-Butyrylalanine

C7H13NO3 (159.0895)


   

3-(2-HYDROXYPROPYL)-5-METHYL-2-OXAZOLIDINONE

3-(2-HYDROXYPROPYL)-5-METHYL-2-OXAZOLIDINONE

C7H13NO3 (159.0895)


   

tert-Butyl acetylcarbamate

tert-Butyl acetylcarbamate

C7H13NO3 (159.0895)


   

Methyl 3-morpholinylacetate

Methyl 3-morpholinylacetate

C7H13NO3 (159.0895)


   

Methyl 4-Hydroxypiperidine-3-carboxylate

Methyl 4-Hydroxypiperidine-3-carboxylate

C7H13NO3 (159.0895)


A piperidinecarboxylate ester that is the methyl ester of 4-hydroxypiperidine-3-carboxylic acid.

   

2-butyryl amino propionic acid

2-butyryl amino propionic acid

C7H13NO3 (159.0895)


   

(2,5-dimethoxy-2H-furan-5-yl)methanamine

(2,5-dimethoxy-2H-furan-5-yl)methanamine

C7H13NO3 (159.0895)


   

l-4-tetrahydropyranylglycine

l-4-tetrahydropyranylglycine

C7H13NO3 (159.0895)


   

Methyl 4-hydroxypiperidine-2-carboxylate

Methyl 4-hydroxypiperidine-2-carboxylate

C7H13NO3 (159.0895)


A piperidinecarboxylate ester that is the methyl ester of 4-hydroxypiperidine-2-carboxylic acid.

   

N-Formyl-L-leucine

N-Formyl-L-leucine

C7H13NO3 (159.0895)


   

Amino(tetrahydro-2H-pyran-4-yl)acetic acid

Amino(tetrahydro-2H-pyran-4-yl)acetic acid

C7H13NO3 (159.0895)


   

(R)-1-METHYL-4-HYDROXY-L-PROLINE METHYL ESTER

(R)-1-METHYL-4-HYDROXY-L-PROLINE METHYL ESTER

C7H13NO3 (159.0895)


   

(S)-(+)-N-acetyl-serine methylester

(S)-(+)-N-acetyl-serine methylester

C7H13NO3 (159.0895)


   

2-Piperidinecarboxylicacid,5-hydroxy-,methylester,(2S,5S)

2-Piperidinecarboxylicacid,5-hydroxy-,methylester,(2S,5S)

C7H13NO3 (159.0895)


   

Cyclohexyldisilylamine

Cyclohexyldisilylamine

C6H17NSi2 (159.0899)


   

L-Proline, 4-hydroxy-, ethyl ester, (4R)- (9CI)

L-Proline, 4-hydroxy-, ethyl ester, (4R)- (9CI)

C7H13NO3 (159.0895)


   

3-NITROANISOLE

3-NITROANISOLE

C7H13NO3 (159.0895)


   

Methyl 3-hydroxypiperidine-1-carboxylate

Methyl 3-hydroxypiperidine-1-carboxylate

C7H13NO3 (159.0895)


A piperidinecarboxylate ester that is the methyl ester of 3-hydroxypiperidine-1-carboxylic acid.

   

2,2,5,5-Tetramethyl-1,2,5-azadisilolidine

1-Aza-2,5-disilacyclopentane, 2,2,5,5-tetramethyl-

C6H17NSi2 (159.0899)


   

ac-d-nva-oh

ac-d-nva-oh

C7H13NO3 (159.0895)


   

3-(propan-2-ylcarbamoyl)propanoic acid

3-(propan-2-ylcarbamoyl)propanoic acid

C7H13NO3 (159.0895)


   

Ac-D-Val-OH

Ac-D-Val-OH

C7H13NO3 (159.0895)


   

Ethyl Morpholine-2-carboxylate

Ethyl Morpholine-2-carboxylate

C7H13NO3 (159.0895)


   

N-methylpyrrolidine-1-carbothiohydrazide

N-methylpyrrolidine-1-carbothiohydrazide

C6H13N3S (159.083)


   

Methyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate

Methyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate

C7H13NO3 (159.0895)


A carbamate ester that is the methyl ester of 2-(hydroxymethyl)pyrrolidine-1-carboxylic acid.

   

Methyl 5-hydroxypiperidine-2-carboxylate

Methyl 5-hydroxypiperidine-2-carboxylate

C7H13NO3 (159.0895)


A piperidinecarboxylate ester that is the methyl ester of 5-hydroxypiperidine-2-carboxylic acid.

   

Methyl 3-(hydroxymethyl)pyrrolidine-1-carboxylate

Methyl 3-(hydroxymethyl)pyrrolidine-1-carboxylate

C7H13NO3 (159.0895)


A carbamate ester that is the methyl ester of 3-(hydroxymethyl)pyrrolidine-1-carboxylic acid.

   

Methyl 5-(hydroxymethyl)pyrrolidine-2-carboxylate

Methyl 5-(hydroxymethyl)pyrrolidine-2-carboxylate

C7H13NO3 (159.0895)


The methyl ester of 5-(hydroxymethyl)pyrrolidine-2-carboxylic acid.

   

1-Amino-2,3-dihydroxy-5-hydroxymethyl cyclohex-5-ene

1-Amino-2,3-dihydroxy-5-hydroxymethyl cyclohex-5-ene

C7H13NO3 (159.0895)


   

betonicine

trans-4-Hydroxy-L-proline betaine

C7H13NO3 (159.0895)


An amino-acid betaine that is trans-4-hydroxy-L-proline zwitterion in which both of the hydrogens attached to the nitrogen have been replaced by methyl groups.

   

5-acetamidopentanoic acid

5-acetamidopentanoic acid

C7H13NO3 (159.0895)


A member of the class of acetamides that is the acetyl derivative of 5-aminopentanoic acid.

   

Calystegin A3

Calystegin A3

C7H13NO3 (159.0895)


   

2-pentanamidoacetic acid

2-pentanamidoacetic acid

C7H13NO3 (159.0895)


   

Methyl 5-(hydroxymethyl)pyrrolidine-3-carboxylate

Methyl 5-(hydroxymethyl)pyrrolidine-3-carboxylate

C7H13NO3 (159.0895)


The methyl ester of 5-(hydroxymethyl)pyrrolidine-3-carboxylic acid.

   

N-Acetyl-L-valine

2-Acetamido-3-methylbutanoic acid

C7H13NO3 (159.0895)


   

N-(2-methylbutanoyl)glycine

N-(2-methylbutanoyl)glycine

C7H13NO3 (159.0895)


A N-acylglycine that is glycine substituted by a 2-methylbutanoyl group at the N atom.

   

cis-4-hydroxy-D-proline betaine

cis-4-hydroxy-D-proline betaine

C7H13NO3 (159.0895)


An amino-acid betaine that is trans-4-hydroxy-D-proline zwitterion in which both of the hydrogens attached to the nitrogen have been replaced by methyl groups.

   

Acetamidovaleric acid

Acetamidovaleric acid

C7H13NO3 (159.0895)


   
   
   

Hydroxystachydrine

Hydroxystachydrine

C7H13NO3 (159.0895)


   

Methylbutyrylglycine

Methylbutyrylglycine

C7H13NO3 (159.0895)


   

Dehydrocarnitine

Dehydrocarnitine

C7H13NO3 (159.0895)


   

(1s,2s,5s,7s)-8-azabicyclo[3.2.1]octane-1,2,7-triol

(1s,2s,5s,7s)-8-azabicyclo[3.2.1]octane-1,2,7-triol

C7H13NO3 (159.0895)


   

5-[(1-hydroxyethylidene)amino]pentanoic acid

5-[(1-hydroxyethylidene)amino]pentanoic acid

C7H13NO3 (159.0895)


   

(1r,2s,3s,5r)-8-azabicyclo[3.2.1]octane-1,2,3-triol

(1r,2s,3s,5r)-8-azabicyclo[3.2.1]octane-1,2,3-triol

C7H13NO3 (159.0895)


   

2α,3β,23-trihydroxynortropane

NA

C7H13NO3 (159.0895)


{"Ingredient_id": "HBIN005209","Ingredient_name": "2\u03b1,3\u03b2,23-trihydroxynortropane","Alias": "NA","Ingredient_formula": "C7H13NO3","Ingredient_Smile": "C1C2C(CC(N2)C(C1O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21809","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2α,3β,4α-trihydroxynortropane

NA

C7H13NO3 (159.0895)


{"Ingredient_id": "HBIN005216","Ingredient_name": "2\u03b1,3\u03b2,4\u03b1-trihydroxynortropane","Alias": "NA","Ingredient_formula": "C7H13NO3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21799","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2α,3β,6-exo-trihydroxynortropane

NA

C7H13NO3 (159.0895)


{"Ingredient_id": "HBIN005218","Ingredient_name": "2\u03b1,3\u03b2,6-exo-trihydroxynortropane","Alias": "NA","Ingredient_formula": "C7H13NO3","Ingredient_Smile": "C1C2C(CC(N2)C(C1O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21800","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2s,4e)-2-amino-6-hydroxy-4-methylhex-4-enoic acid

(2s,4e)-2-amino-6-hydroxy-4-methylhex-4-enoic acid

C7H13NO3 (159.0895)


   

(1s,2r,3s,5s)-8-azabicyclo[3.2.1]octane-1,2,3-triol

(1s,2r,3s,5s)-8-azabicyclo[3.2.1]octane-1,2,3-triol

C7H13NO3 (159.0895)


   

(2r,4r)-4-methoxypiperidine-2-carboxylic acid

(2r,4r)-4-methoxypiperidine-2-carboxylic acid

C7H13NO3 (159.0895)


   

(1r,3s,4s,5r)-8-azabicyclo[3.2.1]octane-1,3,4-triol

(1r,3s,4s,5r)-8-azabicyclo[3.2.1]octane-1,3,4-triol

C7H13NO3 (159.0895)


   

(2r,4s)-4-methoxy-1-methylpyrrolidine-2-carboxylic acid

(2r,4s)-4-methoxy-1-methylpyrrolidine-2-carboxylic acid

C7H13NO3 (159.0895)


   

2-amino-6-hydroxy-5-methylhex-4-enoic acid

2-amino-6-hydroxy-5-methylhex-4-enoic acid

C7H13NO3 (159.0895)


   

4-methoxy-1-methylpyrrolidine-2-carboxylic acid

4-methoxy-1-methylpyrrolidine-2-carboxylic acid

C7H13NO3 (159.0895)


   

2-amino-6-hydroxy-4-methylhex-4-enoic acid

2-amino-6-hydroxy-4-methylhex-4-enoic acid

C7H13NO3 (159.0895)


   

(2s,4e)-2-amino-6-hydroxy-5-methylhex-4-enoic acid

(2s,4e)-2-amino-6-hydroxy-5-methylhex-4-enoic acid

C7H13NO3 (159.0895)


   

(1r,2s,3r,4r,5s)-8-azabicyclo[3.2.1]octane-2,3,4-triol

(1r,2s,3r,4r,5s)-8-azabicyclo[3.2.1]octane-2,3,4-triol

C7H13NO3 (159.0895)


   

(2s)-1-(3-hydroxypropyl)azetidine-2-carboxylic acid

(2s)-1-(3-hydroxypropyl)azetidine-2-carboxylic acid

C7H13NO3 (159.0895)


   

(2s,4r)-4-hydroxy-1-methylpiperidine-2-carboxylic acid

(2s,4r)-4-hydroxy-1-methylpiperidine-2-carboxylic acid

C7H13NO3 (159.0895)


   

(2s,4s)-4-methoxypiperidine-2-carboxylic acid

(2s,4s)-4-methoxypiperidine-2-carboxylic acid

C7H13NO3 (159.0895)


   

(2s,4r)-4-methoxy-1-methylpyrrolidine-2-carboxylic acid

(2s,4r)-4-methoxy-1-methylpyrrolidine-2-carboxylic acid

C7H13NO3 (159.0895)


   

(1r,2s,3r,5r)-8-azabicyclo[3.2.1]octane-1,2,3-triol

(1r,2s,3r,5r)-8-azabicyclo[3.2.1]octane-1,2,3-triol

C7H13NO3 (159.0895)


   

(1s,2r,3r,5s,6r)-8-azabicyclo[3.2.1]octane-2,3,6-triol

(1s,2r,3r,5s,6r)-8-azabicyclo[3.2.1]octane-2,3,6-triol

C7H13NO3 (159.0895)